Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention
Author:
Funder
Abbott Japan Co Ltd
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference32 articles.
1. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial;Watanabe;JAMA,2019
2. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
3. Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial;Hahn;JAMA,2019
4. Ticagrelor with or without aspirin in high-risk patients after PCI;Mehran;N Engl J Med,2019
5. Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial;Kim;JAMA,2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clopidogrel: Drug of the Past or Drug of the Future?;Cardiovascular Drugs and Therapy;2024-09-09
2. Antithrombotic management in atrial fibrillation patients following percutaneous coronary intervention: A clinical review;Journal of Arrhythmia;2024-08-08
3. Clopidogrel induced reduction in neutrophil count: An overlooked beneficial effect?;European Journal of Internal Medicine;2024-06
4. One-Month Dual Antiplatelet Therapy Followed by P2Y<sub>12</sub> Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation ― The REIWA Region-Wide Registry ―;Circulation Journal;2024-05-24
5. Monotherapy with P2Y12-inhibitors after dual antiplatelet therapy: Filling gaps in evidence;International Journal of Cardiology;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3